Alzheimers Disease Neuroimaging Initiative 3 (ADNI3) | Clinical Research Studies Listing

Recruiting

55 years - 90 years

All

Phase N/A

23 participants needed

1 Location

Brief description of study

Since its launch in 2004, the overarching aim of the Alzheimer’s Disease Neuroimaging Initiative (ADNI) has been realized in informing the design of therapeutic trials in AD. ADNI3 continues the previously funded ADNI1, ADNI-GO, and ADNI2 studies that have been combined public/private collaborations between academia and industry to determine the relationships between the clinical, cognitive, imaging, genetic and biochemical biomarker characteristics of the entire spectrum of Alzheimer’s disease (AD).

ADNI3 is the latest phase of the initiative. It is a non-treatment clinical research study to discover, optimize, standardize, and validate clinical trial measures and biomarkers used in ongoing AD research.

Data from this research will help determine the best measures for diagnosis and disease monitoring , which will be used to accelerate the testing of therapeutic interventions and ultimately, improve Alzheimer's disease prevention and care.

Detailed description of study

Who can participate?

Individuals who are 55-90, who have a diagnosis of Mild Cognitive Impairment (MCI or Alzheimer's Disease (AD). Who have a reliable study partner who has frequent contact and who can accompanying you to the study visits for the duration on the study and who are willing to participate in repeated imaging and biomarker collection.

What does the study include?

If you agree and are eligible to participate in the study, you will be asked to come in for:

an initial screening visit and baseline visit
an annual or biannual follow-up clinic visit

Screening Procedures include:

Brain imaging such as MRI and PET/CT scans
Memory Testing
Physical and Neurological Exam
Lumbar Puncture
Blood Draw

Before enrolling into the study, the participant and study partner must read, understand, and sign a formal consent, which fully explains the study.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: MCI,AD
Age: 55 years - 90 years
Gender: All

Updated on 19 Feb 2024. Study ID: 825666

Find a site

Your Information has been sent successfully.

Message sent successfully.

We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.

If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.

Send a message

Enter your contact details to connect with study team

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).